Indivior PLC (LON:INDV - Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 738.66 ($9.82) and traded as high as GBX 893 ($11.87). Indivior shares last traded at GBX 888 ($11.81), with a volume of 234,673 shares traded.
Indivior Price Performance
The company has a market capitalization of £1.31 billion, a P/E ratio of -697.73, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The business's fifty day moving average price is GBX 749.80 and its 200-day moving average price is GBX 815.09.
Indivior Company Profile
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
